ResMed Total Current Assets increased by 6.4% to $4.06B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 26.7%, from $3.21B to $4.06B. Over 4 years (FY 2021 to FY 2025), Total Current Assets shows an upward trend with a 22.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Higher levels indicate stronger short-term liquidity, though excessive levels may suggest inefficient capital allocation.
The sum of all assets that are expected to be converted into cash or consumed within one year. This provides a snapshot...
Compared against current liabilities to determine the current ratio, a standard measure of short-term financial health.
total_current_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.57B | $1.59B | $1.55B | $1.70B | $1.93B | $2.03B | $2.33B | $2.34B | $2.37B | $2.30B | $2.38B | $2.35B | $2.36B | $2.64B | $2.84B | $3.21B | $3.51B | $3.63B | $3.82B | $4.06B |
| QoQ Change | — | +0.7% | -2.5% | +10.2% | +13.3% | +5.3% | +14.3% | +0.5% | +1.3% | -2.7% | +3.2% | -1.1% | +0.3% | +12.0% | +7.4% | +13.1% | +9.3% | +3.4% | +5.3% | +6.4% |
| YoY Change | — | — | — | — | +22.7% | +28.2% | +50.3% | +37.2% | +22.6% | +13.3% | +2.3% | +0.6% | -0.4% | +14.6% | +19.3% | +36.5% | +48.7% | +37.3% | +34.6% | +26.7% |